CS299091A3 - 4- or 5-substituted pyridine-2-carboxylic acids, process of their preparation as well as their application as medicaments - Google Patents
4- or 5-substituted pyridine-2-carboxylic acids, process of their preparation as well as their application as medicamentsInfo
- Publication number
- CS299091A3 CS299091A3 CS912990A CS299091A CS299091A3 CS 299091 A3 CS299091 A3 CS 299091A3 CS 912990 A CS912990 A CS 912990A CS 299091 A CS299091 A CS 299091A CS 299091 A3 CS299091 A3 CS 299091A3
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- medicaments
- preparation
- well
- application
- carboxylic acids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
- C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4030999A DE4030999A1 (de) | 1990-10-01 | 1990-10-01 | 4- oder 5-substituierte pyridin-2-carbonsaeuren, verfahren zu deren herstellung sowie deren verwendung als arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
CS299091A3 true CS299091A3 (en) | 1992-04-15 |
Family
ID=6415344
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS912990A CS299091A3 (en) | 1990-10-01 | 1991-09-30 | 4- or 5-substituted pyridine-2-carboxylic acids, process of their preparation as well as their application as medicaments |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0479178A3 (ja) |
JP (1) | JPH072777A (ja) |
KR (1) | KR920008000A (ja) |
CN (1) | CN1060464A (ja) |
AU (1) | AU8485191A (ja) |
BR (1) | BR9104204A (ja) |
CA (1) | CA2052509A1 (ja) |
CS (1) | CS299091A3 (ja) |
DE (1) | DE4030999A1 (ja) |
FI (1) | FI914557A (ja) |
HU (1) | HUT59101A (ja) |
IE (1) | IE913436A1 (ja) |
IL (1) | IL99606A0 (ja) |
MA (1) | MA22312A1 (ja) |
MX (1) | MX9101348A (ja) |
NO (1) | NO913833L (ja) |
PL (1) | PL291880A1 (ja) |
PT (1) | PT99133A (ja) |
ZA (1) | ZA917806B (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW199147B (ja) * | 1991-03-18 | 1993-02-01 | Hoechst Ag | |
WO2017161555A1 (zh) * | 2016-03-25 | 2017-09-28 | 沈阳三生制药有限责任公司 | 用于合成被芳基或杂芳基取代的5-羟基-1,7-萘啶化合物的中间体及其制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3432094A1 (de) * | 1984-08-31 | 1986-03-06 | Hoechst Ag, 6230 Frankfurt | Ester der pyridin-2,4- und -2,5- dicarbonsaeure als arzneimittel zur inhibierung der prolin- und lysinhydroxylase |
DE3703963A1 (de) * | 1987-02-10 | 1988-08-18 | Hoechst Ag | Pyridin-2,4- und 2,,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben, sowie arzneimittel auf basis dieser verbindungen |
DE3707429A1 (de) * | 1987-03-07 | 1988-09-15 | Hoechst Ag | Substituierte pyridin-2,4-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen |
DE3924093A1 (de) * | 1989-07-20 | 1991-02-07 | Hoechst Ag | N,n'-bis(alkoxy-alkyl)-pyridin-2,4-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung |
-
1990
- 1990-10-01 DE DE4030999A patent/DE4030999A1/de not_active Withdrawn
-
1991
- 1991-09-27 IL IL99606A patent/IL99606A0/xx unknown
- 1991-09-27 FI FI914557A patent/FI914557A/fi not_active Application Discontinuation
- 1991-09-30 CS CS912990A patent/CS299091A3/cs unknown
- 1991-09-30 HU HU913120A patent/HUT59101A/hu unknown
- 1991-09-30 JP JP3250720A patent/JPH072777A/ja active Pending
- 1991-09-30 KR KR1019910017065A patent/KR920008000A/ko not_active Application Discontinuation
- 1991-09-30 BR BR919104204A patent/BR9104204A/pt unknown
- 1991-09-30 EP EP19910116633 patent/EP0479178A3/de not_active Withdrawn
- 1991-09-30 ZA ZA917806A patent/ZA917806B/xx unknown
- 1991-09-30 IE IE343691A patent/IE913436A1/en not_active Application Discontinuation
- 1991-09-30 CN CN91109397A patent/CN1060464A/zh active Pending
- 1991-09-30 MX MX9101348A patent/MX9101348A/es unknown
- 1991-09-30 AU AU84851/91A patent/AU8485191A/en not_active Abandoned
- 1991-09-30 NO NO91913833A patent/NO913833L/no unknown
- 1991-09-30 PL PL29188091A patent/PL291880A1/xx unknown
- 1991-09-30 CA CA002052509A patent/CA2052509A1/en not_active Abandoned
- 1991-10-01 PT PT99133A patent/PT99133A/pt not_active Application Discontinuation
- 1991-10-01 MA MA22592A patent/MA22312A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
CN1060464A (zh) | 1992-04-22 |
MA22312A1 (fr) | 1992-07-01 |
AU8485191A (en) | 1992-04-02 |
PL291880A1 (en) | 1992-06-26 |
KR920008000A (ko) | 1992-05-27 |
HU913120D0 (en) | 1992-01-28 |
EP0479178A3 (en) | 1992-10-28 |
PT99133A (pt) | 1992-08-31 |
JPH072777A (ja) | 1995-01-06 |
MX9101348A (es) | 1992-06-05 |
EP0479178A2 (de) | 1992-04-08 |
FI914557A (fi) | 1992-04-02 |
CA2052509A1 (en) | 1992-04-02 |
BR9104204A (pt) | 1992-06-02 |
IE913436A1 (en) | 1992-04-08 |
NO913833D0 (no) | 1991-09-30 |
IL99606A0 (en) | 1992-08-18 |
ZA917806B (en) | 1992-05-27 |
FI914557A0 (fi) | 1991-09-27 |
HUT59101A (en) | 1992-04-28 |
DE4030999A1 (de) | 1992-04-09 |
NO913833L (no) | 1992-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL83016A (en) | Heterocyclic alkylenediamines,process for their preparation and their use as insecticides | |
HUT59558A (en) | New 5-chloro-quinoline-8-oxy-alkane-carboxylic acid derivatives, process for producing and utilizing them as antidotum | |
EP0119954A3 (en) | 3-amino-1-benzazepin-2-one-1-alcanoic acids, process for their preparation, their pharmaceutical preparation as well as their therapeutic use | |
HUT46000A (en) | Process for producing imidazo/4,5-b/pyridine derivatives and pharmaceutics comprising these compounds as active ingredient | |
CS409591A3 (en) | Novel derivatives of bicyclic amino acids, process of their preparation, means comprising said compounds and their application, as well as novel bicyclic amino acids as intermediate products and process for preparing thereof | |
AR242187A1 (es) | Procedimiento para la preparacion de 1-hidroxi-2-piridonas, obtencion de medicamentos que las contienen, e intermediarios utiles en dicho procedimiento. | |
PL307328A1 (en) | Novel derivatives of imidazo [1,2-a] pyridine and method of obtaining them as well as pharmaceutical preparation and method of preparing same | |
CS299991A3 (en) | Derivatives of 2-aminopyrimidine-4-carboxamide, process of their preparation and their application as medicaments | |
FI981709A0 (fi) | Menetelmä 5-substituoitujen 2-amino-4-okso-pyrrolo/2,3-d/-pyrimidiinien valmistamiseksi | |
HU901428D0 (en) | Process for the preparation of 5-substituted 1,4-dihydro-4-oxo-naphthiridine-3-carboxylic acid derivatives | |
CS299191A3 (en) | 4- or 5-substituted pyridine-2-carboxylic acids, process of their preparation as well as their application as medicaments | |
IL70659A (en) | Process for the preparation of 2,3-dihalo pyridines | |
AU601787B2 (en) | Substituted aminomethyl-5,6,7,8-tetrahydronaphthyloxy-acetic acids, new intermediate products, processes for their preparation and their use as medicaments | |
CS235091A3 (en) | Novel derivatives of 1-diphenylmethylpiperazine, process of their preparation and their application as medicaments | |
CS299091A3 (en) | 4- or 5-substituted pyridine-2-carboxylic acids, process of their preparation as well as their application as medicaments | |
AU7726187A (en) | 2,3-dihydrofuran derivatives, process for preparing them, and their use as an intermediate for the preparation of tetrahydrofuran derivatives | |
EP0297496A3 (en) | Novel process for the preparation of 6,7-diacyl-7-deacetylforskolin derivatives | |
AU7828287A (en) | Method for the preparation of pyridine-2,3-dicarboxylic acids | |
ZA79271B (en) | 1-naphthyl-acetic acid derivatives,process for their preparation and their therapeutic applications | |
CS390991A3 (en) | Thiadiazinone derivatives, process of their preparation andpharmaceuticals based thereon | |
AU5241690A (en) | Process for the preparation of pyridine-2, 3-dicarboxylic acids | |
AU6947791A (en) | Process for the preparation of pyrazolecarboxylic acid derivatives | |
HUT47109A (en) | Process for producing 3-(acylaminomethyl)-5,6,7,8-tetrahydro-imidazo-(1,2-a)pyridine derivatives and pharmaceutical compositions comprising these compounds | |
IE901504L (en) | Derivatives of 4-phenylmethyl-1h-indole, process and¹intermediates of preparation, application as medicaments and¹compositions containing them | |
DE3560004D1 (en) | Substituted salicylamides, process for their production and their use as pharmaceutical preparations |